Quantitative analysis of eicosanoids in biological samples by LC–MS/MS: Mission accomplished?

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 1012-1013, Issue , 2016, Pages 211-214

  Tsikas, Dimitrios ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Arachidonic acid; Biological samples; Eicosanoids; Quantitation; Tandem mass spectrometry; Validation

Indexed keywords

ICOSANOID;

ANALYTIC METHOD; CONCENTRATION PROCESS; DRUG BLOOD LEVEL; DRUG URINE LEVEL; HUMAN; LIPID ANALYSIS; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; NOTE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY; URINALYSIS; VALIDATION PROCESS; BLOOD; FEMALE; MALE; PROCEDURES; REPRODUCIBILITY; STATISTICAL MODEL;

CHROMATOGRAPHY, LIQUID; EICOSANOIDS; FEMALE; HUMANS; LINEAR MODELS; MALE; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY;

EID: 84928531427     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2015.04.018     Document Type: Note

References (21)

1. [1] Montuschi, P., LC/MS/MS analysis of leukotriene B4 and other eicosanoids in exhaled breath condensate for assessing lung inflammation. J. Chromatogr. B 877 (2009), 1272–1280.
2. [2] Tsikas, D., Zoerner, A.A., Analysis of eicosanoids, amino acids, organic acids, and microRNAs. J. Chromatogr. B, 964, 2014 VII–VIII.
3. [3] Kortz, L., Dorow, J., Ceglarek, U., Liquid chromatography–tandem mass spectrometry for the analysis of eicosanoids and related lipids in human biological matrices: a review. J. Chromatogr. B 964 (2014), 1–11.
4. [4] Montuschi, P., Santini, G., Valente, S., Mondino, C., Macagno, F., Cattani, P., Zini, G., Mores, N., Liquid chromatography–mass spectrometry measurement of leukotrienes in asthma and other respiratory diseases. J. Chromatogr. B 964 (2014), 12–25.
5. [5] Porro, B., Songia, P., Squellerio, I., Tremoli, E., Cavalca, V., Analysis, physiological and clinical significance of 12-HETE: a neglected platelet-derived 12-lipoxygenase product. J. Chromatogr. B 964 (2014), 26–40.
6. [6] Martin-Venegas, R., Jáuregui, O., Moreno, J.J., Liquid chromatography-tandem mass spectrometry analysis of eicosanoids and related compounds in cell models. J. Chromatogr. B 964 (2014), 41–49.
7. [7] Puppolo, M., Varma, D., Jansen, S.A., A review of analytical methods for eicosanoids in brain tissue. J. Chromatogr. B 964 (2014), 50–64.
8. [8] Vigor, C., Bertrand-Michel, J., Pinot, E., Oger, C., Vercauteren, J., Le Faouder, P., Galano, J.-M., Chung-Yung Lee, J., Durand, T., Non-enzymatic lipid oxidation products in biological systems: assessment of the metabolites from polyunsaturated fatty acids. J. Chromatogr. B 964 (2014), 65–78.
9. [9] Tsikas, D., Zoerner, A.A., Analysis of eicosanoids by LC–MS/MS and GC–MS/MS: a historical retrospect and a discussion. J. Chromatogr. B 964 (2014), 79–88.
10. [10] Tsikas, D., Application of gas chromatography-mass spectrometry and gas chromatography-tandem mass spectrometry to assess in vivo synthesis of prostaglandins, thromboxane, leukotrienes, isoprostanes and related compounds in humans. J. Chromatogr. B 717 (1998), 201–245.
11. [11] Gika, H.G., Wilson, I.D., Theodoridis, G.A., LC–MS-based holistic metabolic profiling. Problems, limitations, advantages, and future perspectives. J. Chromatogr. B 966 (2014), 1–6.
12. [12] Gachet, M.S., Rhyn, P., Bosch, O.G., Quednow, B.B., Gertsch, J., A quantitiative LC-MS/MS method for the measurement of arachidonic acid, prostanoids, endocannabinoids, N-acylethanolamines and steroids in human plasma. J. Chromatogr. B 976–977 (2015), 6–18.
13. [13] Zoerner, A.A., Gutzki, F.M., Batkai, S., May, M., Rakers, C., Engeli, S., Jordan, J., Tsikas, D., Quantification of endocannabinoids in biological systems by chromatography and mass spectrometry: a comprehensive review from an analytical and biological perspective. Biochim. Biophys. Acta 1811 (2011), 706–723.
14. [14] Zoerner, A.A., Batkai, S., Suchy, M.T., Gutzki, F.M., Engeli, S., Jordan, J., Tsikas, D., Simultaneous UPLC–MS/MS quantification of the endocannabinoids 2-arachidonoyl glycerol (2AG), 1-arachidonoyl glycerol (1AG), and anandamide in human plasma: minimization of matrix-effects, 2AG/1AG isomerization and degradation by toluene solvent extraction. J. Chromatogr. B 883–884 (2012), 161–171.
15. [15] Zoerner, A.A., Gutzki, F.M., Suchy, M.T., Beckmann, B., Engeli, S., Jordan, J., Tsikas, D., Targeted stable-isotope dilution GC–MS/MS analysis of the endocannabinoid anandamide and other fatty acid ethanol amides in human plasma. J. Chromatogr. B 877 (2009), 2909–2923.
16. [16] Tsikas, D., A proposal for comparing methods of quantitative analysis of endogenous compounds in biological systems by using the relative lower limit of quantification (rLLOQ). J. Chromatogr. B 877 (2009), 2244–2251.
17. [17] Araujo, P., Key aspects of analytical method validation and linearity evaluation. J. Chromatogr. B 877 (2009), 2224–2234.
18. [18] Schweer, H., Kammer, J., Seyberth, H.W., Simultaneous determination of prostanoids in plasma by gas chromatography-negative-ion chemical-ionization mass spectrometry. J. Chromatogr. 338 (1985), 273–280.
19. [19] Komada, J., Matsuda, D., Shibakawa, K., Nakade, S., Hashimoto, Y., Miyata, Y., Ogawa, M., Development and validation of an on-line two-dimensional reversed-phase liquid chromatography-tandem mass spectrometry method for the simultaneous determination of prostaglandins E(2) and F(2alpha) and 13,14-dihydro-15-keto prostaglandin F(2alpha) levels in human plasma. Biomed. Chromatogr. 23 (2009), 315–323.
20. [20] Quehenberger, O., Armando, A.M., Brown, A.H., Milne, S.B., Myers, D.S., Merrill, A.H., Bandyopadhyay, S., Jones, K.N., Kelly, S., Shaner, R.L., Sullards, C.M., Wang, E., Murphy, R.C., Barkley, R.M., Leiker, T.J., Raetz, C.R.H., Guan, Z., Laird, G.M., Six, D.A., Russell, D.W., McDonald, J.G., Subramaniam, S., Fahy, E., Dennis, E.A., Lipidomics reveals a remarkable diversity of lipids in human plasma. J. Lip. Res. 51 (2010), 3299–3305.
21. [21] Duncan, M., Good mass spectrometry and its place in good science. J. Mass Spectrom. 47 (2012), 795–809.